Conviction
$ Value
$273K
Shares
20,000
Price
$14
Filed
Oct 21
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Hawryluk P. Kent
Title
President & CEO
CIK
0001673991
Roles
Transaction Details
Transaction Date
2025-10-20
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
468,277
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.60 to $13.6399, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | Shares held by the P. Kent Hawryluk Revocable Trust dated January 25, 2011, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
Filing Info
Hawryluk P. Kent's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-13 | MBX | ▲ | $526K ★ |
| 2026-02-26 | MBX | M | $460K |
| 2026-02-26 | MBX | M | $0 |
| 2026-02-02 | MBX | A | $0 |
| 2026-02-02 | MBX | A | $0 |
| 2025-10-24 | MBX | M | $594K |
| 2025-10-24 | MBX | M | $0 |
| 2025-10-20 | MBX | ▲ | $273K |
Other Insiders at MBX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hawryluk P. Kent
President & CEO
|
$526K | — | 2026-03-13 |
| Hoerter Steven L. | — | — | 2025-11-22 |
|
Bartram Richard
Chief Financial Officer
|
— | — | 2026-02-02 |
|
Azoulay Salomon
Chief Medical Officer
|
— | — | 2026-02-02 |